Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q36919799

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Low WT1 transcript levels at d ...... tic stem cell transplantation.

@en

type

Item

label

Low WT1 transcript levels at d ...... tic stem cell transplantation.

@en

prefLabel

Low WT1 transcript levels at d ...... tic stem cell transplantation.

@en

P1476

Low WT1 transcript levels at d ...... tic stem cell transplantation.

@en

P2093

Bin Jiang

http://www.w3.org/2001/XMLSchema#string

Hao Jiang

http://www.w3.org/2001/XMLSchema#string

Hong-Hu Zhu

http://www.w3.org/2001/XMLSchema#string

Huan Chen

http://www.w3.org/2001/XMLSchema#string

Kai-Yan Liu

http://www.w3.org/2001/XMLSchema#string

Lan-Ping Xu

http://www.w3.org/2001/XMLSchema#string

Mei-Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Qian Jiang

http://www.w3.org/2001/XMLSchema#string

Xiao-Hui Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Jun Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

P2888

s40880-016-0110-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40880-016-0110-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert Peter Gale

P577

2016-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029800110

http://www.w3.org/2001/XMLSchema#string

P698

27197573

http://www.w3.org/2001/XMLSchema#string

P932

4873994

http://www.w3.org/2001/XMLSchema#string